Physician profile
Joyce Lin
NPI 1427681022
$1,665.60
in general payments reported to CMS, 2019-2025
10 companies · $509 in 2025
The $509 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $223 · 2022: $125 · 2023: $430 · 2024: $378 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $553.98 | 2023-2025 | Trodelvy |
| Astrazeneca Pharmaceuticals LP | $349.54 | 2024-2025 | Enhertu, Datroway |
| Daiichi Sankyo INC. | $124.99 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2024 | |
| Emd Serono, INC. | $121.22 | 2021 | |
| Ucb, INC. | $118.07 | 2024 | Bimzelx |
| Seagen INC. | $102.20 | 2021 | |
| Baxter Healthcare | $85.31 | 2023 | Floseal, Tisseel, Seprafilm |
| Boston Scientific Corporation | $72.15 | 2023 | |
| Janssen Scientific Affairs, LLC | $16.30 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.